|1.||Kulik, Alexander: 2 articles (05/2015 - 02/2007)|
|2.||Inchiosa, Mario A: 2 articles (01/2013 - 03/2008)|
|3.||Shamberger, Robert C: 2 articles (02/2009 - 07/2005)|
|4.||Seefelder, Christian: 2 articles (02/2009 - 07/2005)|
|5.||Motta, Pablo: 2 articles (03/2008 - 02/2005)|
|6.||Toscana, Diego: 2 articles (03/2008 - 02/2005)|
|7.||Mossad, Emad: 2 articles (03/2008 - 02/2005)|
|8.||Li, Han-zhong: 2 articles (06/2005 - 09/2004)|
|9.||Pan, Dong-liang: 2 articles (06/2005 - 09/2004)|
|10.||Zeng, Zheng-pei: 2 articles (06/2005 - 09/2004)|
06/01/1990 - "This prospective clinical study evaluates the possible beneficial effects of increased phenoxybenzamine dosage in the preoperative treatment of patients with pheochromocytoma. "
05/01/2007 - "A pheochromocytoma was suspected, and phenoxybenzamine was added to her treatment regimen. "
05/01/2005 - "After recompensation and subsequent administration of phenoxybenzamine a benign pheochromocytoma was resected. "
10/01/2004 - "Chronomically interpreted monitoring revealed: 1) the persistence of a statistically significant circadian rhythm during 12-hourly phenoxybenzamine treatment; 2) days-long changes in BP MESOR, the duration of which could not be previously determined based on spotchecks; 3) changes in the circadian amplitude of BP, which can be either very small or very large, compatible with the diagnosis of intermittent circadian hyper-amplitude-tension (CHAT); and 4) a very wide range of BP and HR values, so that occasional (casual) measurements fail to convey the dynamics that may underlie this infrequently found clinical condition of an elevated catecholamine excretion compatible with a pheochromocytoma. "
10/01/2004 - "Circadian hypo- and hyper-amplitude-tension (CHAT) associated with putative pheochromocytoma and 12-hourly phenoxybenzamine treatment."
10/01/1988 - "Phenoxybenzamine and urinary retention."
01/01/1988 - "In 21 of these 26 patients, urinary retention disappeared within 48 hours following phenoxybenzamine administration."
09/01/1985 - "Prophylactic phenoxybenzamine treatment is recommended as an alternative to routine bladder drainage in preventing urinary retention following vaginal repair operations for genital descensus."
03/01/1978 - "In one group of 21 patients who received phenoxybenzamine prophylactically only one patient had urinary retention develop; nine of 22 patients in the control group who did not receive prophylactic phenoxybenzamine postoperatively had urinary retention develop. "
01/01/1987 - "The efficacy of phenoxybenzamine in preventing postoperative urinary retention after total hip arthroplasty was investigated in a double-blind placebo-controlled study on 60 consecutive male patients with obstructive urinary symptoms. "
01/01/2014 - "In phenoxybenzamine group, ten patients had sharp fluctuations in blood pressure during surgery, and no hypertensive crisis and hypotensive shock appeared after surgery. "
01/01/1987 - "Liver blood flow during haemorrhagic shock in the dog treated with phenoxybenzamine."
01/01/1982 - "They express the hypothesis of an inhibition hyper-reflex of sympathetic origin, reversible under phenoxybenzamine treatment, consider the urodynamic evaluation and the therapeutic treatment and compare this type of neurogenic vesical dysfunction to that of the spinal shock."
12/01/1980 - "Treatment of severe shock with phenoxybenzamine."
05/01/1977 - "When compared to the untreated shock animals, phenoxybenzamine caused an 83% increase in RBF and a 53% decrease in RVR. "
01/01/2012 - "Finally, phenoxybenzamine improved his pain significantly. "
05/01/1981 - "Rest pain, local tenderness, trophic skin changes, and vasospastic phenomena improved in the majority of patients soon after beginning treatment with phenoxybenzamine. "
01/01/2013 - "Also, a recent study identified phenoxybenzamine as a potential intervention for pain mediation from its effects on gene expression in human cell lines; on this basis, it was tested and found to be capable of reducing pain behavior in a classical animal model of chronic pain. "
01/01/2010 - "Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping."
01/01/2013 - "Phenoxybenzamine in complex regional pain syndrome: potential role and novel mechanisms."
|5.||Hypotension (Low Blood Pressure)
01/01/1984 - "Phenoxybenzamine with fluid infusion improved SMA flow, despite the low blood pressure. "
05/01/2014 - "Perioperative haemodynamics seem to be slightly better controlled with phenoxybenzamine, at the cost of more pronounced postoperative hypotension. "
09/01/1997 - "Therefore, postoperative hypotension is a hazard of therapy with phenoxybenzamine if adequate plasma volume repletion is not provided. "
11/01/1996 - "Because of the placental transfer of phenoxybenzamine, mild perinatal depression and transient hypotension may occur in newborns of mothers receiving this medication. "
11/01/1996 - "Mean concentrations of phenoxybenzamine from cord and maternal plasma and in amniotic fluid were 103.3, 66, and 79.3 ng/mL, respectively; the newborn's plasma concentration at 32 hours of life was 22.3 ng/mL. At the time of delivery, the 2475-g male infant exhibited perinatal depression; mild transient hypotension was also noted for the first few days of life. "
|3.||Adrenergic Receptors (Adrenergic Receptor)
|6.||Adrenergic Antagonists (Antiadrenergic Agents)
|2.||Cardiopulmonary Bypass (Heart-Lung Bypass)
|5.||Deep Hypothermia Induced Circulatory Arrest